华兰生物: 2025年半年度利润分配预案的公告

Core Viewpoint - The company has proposed a profit distribution plan for the first half of 2025, aiming to enhance shareholder returns while ensuring sustainable business operations [1][2][3]. Profit Distribution Plan - The proposed cash dividend amounts to 913,728,333.00 yuan (including tax), which represents 177.13% of the net profit attributable to shareholders for the first half of 2025 [2][3]. - The total undistributed profits available for distribution to shareholders as of June 30, 2025, is 2,761,106,442.53 yuan, with total share capital of 1,827,456,666 shares [1][2]. Rationale for Cash Dividend - The cash dividend proposal considers the company's profitability, cash flow, debt repayment capacity, and future funding needs, ensuring it does not impact normal operations and future development [2][3]. - The company aims to respond to investor demands for increased dividends while aligning with its operational performance and long-term development plans [3][4]. Future Development and Financial Health - The company is committed to high-quality and stable growth, with plans to enhance dividend stability and predictability, thereby increasing long-term investment value [4][5]. - As of the end of the first half of 2025, the company holds cash and cash equivalents totaling 7.69 billion yuan, representing 55.04% of its net assets, indicating a strong liquidity position [5].